BioVie Inc. (NASDAQ: BIVI) is 26.51% higher on its value in year-to-date trading and has touched a low of $1.33 and a high of $14.38 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The BIVI stock was last observed hovering at around $9.20 in the last trading session, with the day’s gains setting it 0.63% off its average median price target of $12.00 for the next 12 months. It is also 18.08% off the consensus price target high of $12.00 offered by 3 analysts, but current levels are -40.43% lower than the price target low of $7.00 for the same period.
Currently trading at $9.83, the stock is 39.25% and 62.75% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.64 million and changing 6.85% at the moment leaves the stock 136.32% off its SMA200. BIVI registered 254.87% gain for a year compared to 6-month gain of 272.35%.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
The stock witnessed a 94.27% loss in the last 1 month and extending the period to 3 months gives it a 3.36%, and is 10.33% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.37% over the week and 15.09% over the month.
Distance from 52-week low is 641.89% and -31.64% from its 52-week high.
BioVie Inc. (BIVI) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for BioVie Inc. (BIVI) is a “Buy”. 3 analysts offering their recommendations for the stock have an average rating of 1.70, where 0 rate it as a Hold and 0 think it is a “Overweight”. 3 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
BioVie Inc. is expected to release its quarterly report on 05/31/2023.The EPS is expected to grow by 92.90% this year
BioVie Inc. (BIVI) Top Institutional Holders
The shares outstanding are 31.17M, and float is at 7.04M with Short Float at 5.14%.
BioVie Inc. (BIVI) Insider Activity
A total of 16 insider transactions have happened at BioVie Inc. (BIVI) in the last six months, with sales accounting for 6 and purchases happening 10 times.